Neutrophil-to-apolipoprotein A1 ratio as a novel biomarker for prognosis in anti-NMDAR encephalitis: a retrospective cohort analysis

Key Points

• Neutrophil-to-apolipoprotein A1 ratio serves as an independent predictor of poor prognosis in anti-NMDAR encephalitis, enabling better patient stratification.
• High specificity of this biomarker assists in early identification of high-risk patients, which is crucial for timely intervention.
• Retrospective cohort analysis highlights the prognostic value of neutrophil-to-apolipoprotein A1 ratio, suggesting its potential role in future management strategies.
• Identifying patients at risk of recurrence can improve long-term outcomes, calling for further exploration in clinical settings.

Abstract